Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06245915
What this trial is testing

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Advanced/Metastatic Clear Cell Renal Cell CarcinomaRecurrence
Arsenal Biosciences, Inc. 37
Not applicableUnknownNCT06279104
What this trial is testing

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

Who this might be right for
Ovarian Clear Cell Carcinoma
Tongji Hospital 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT03284385
What this trial is testing

Testing AZD1775 in Advanced Solid Tumors That Have a Mutation Called SETD2

Who this might be right for
Clear Cell Renal Cell CarcinomaLocally Advanced Clear Cell Renal Cell CarcinomaLocally Advanced Malignant Solid Neoplasm+4 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT06835972
What this trial is testing

Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center 43
Large-scale testing (Phase 3)Study completedNCT00006027
What this trial is testing

Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer

Who this might be right for
Endometrial Cancer
Radiation Therapy Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602101
What this trial is testing

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 33
Large-scale testing (Phase 3)Active Not RecruitingNCT00565851
What this trial is testing

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Clear Cell AdenocarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+22 more
National Cancer Institute (NCI) 1,052
Testing effectiveness (Phase 2)Study completedNCT03602586
What this trial is testing

Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer

Who this might be right for
Malignant Ovarian Clear Cell TumorRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 14
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Large-scale testing (Phase 3)Study completedNCT00397345
What this trial is testing

TroVax Renal Immunotherapy Survival Trial

Who this might be right for
Clear Cell Renal Carcinoma
Oxford BioMedica 733
Testing effectiveness (Phase 2)Looking for participantsNCT07571551
What this trial is testing

Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Jinling Hospital, China 75
Testing effectiveness (Phase 2)Looking for participantsNCT06940518
What this trial is testing

Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
IvonescimabClear Cell Renal Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)UnknownNCT01069770
What this trial is testing

Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastasis
Korean Urological Oncology Society 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT05808608
What this trial is testing

AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaFirst-line TreatmentNon Clear Cell Renal Cell Carcinoma+1 more
Hao Zeng 37
Testing effectiveness (Phase 2)Looking for participantsNCT06211790
What this trial is testing

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

Who this might be right for
Kidney CancerRenal Cell CarcinomaRenal Clear Cell Carcinoma
Fudan University 66
Testing effectiveness (Phase 2)Study completedNCT00866320
What this trial is testing

Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT03297424
What this trial is testing

PLX2853 in Advanced Malignancies.

Who this might be right for
Small Cell Lung CancerUveal MelanomaOvarian Clear Cell Carcinoma+5 more
Opna Bio LLC 49
Early research (Phase 1)Study completedNCT04518046
What this trial is testing

Study of Sitravatinib, Nivolumab and Ipilimumab in Advanced or Metastatic Clear-Cell Renal Cell Carcinoma or Other Solid Malignancies

Who this might be right for
Clear-Cell Renal Cell Carcinoma
Mirati Therapeutics Inc. 22
Very early researchStudy completedNCT02111941
What this trial is testing

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more
Mayo Clinic 19
Next Page